Manon Bouchard Selected Research

Levodopa (L Dopa)

12/2023	Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
5/2023	Oral Levodopa, Vitamin B6, and Polyneuropathy: A Case Series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manon Bouchard Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 01/2024 - 11/2021
2	Polyneuropathies (Polyneuropathy) 05/2023 - 01/2023
1	Epilepsy (Aura) 01/2023
1	Dementia (Dementias) 11/2017
1	Hypoglycemia (Reactive Hypoglycemia) 11/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Tyrosinemias (Tyrosinemia) 01/2017
1	Tauopathies 07/2011
1	Congenital torticollis 10/2010

Drug/Important Bio-Agent (IBA)

2	Levodopa (L Dopa)FDA LinkGeneric 12/2023 - 05/2023
2	Vitamin B 6IBA 05/2023 - 01/2023
1	Carbidopa (Lodosyn)FDA LinkGeneric 12/2023
1	ProdrugsIBA 12/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2017
1	nitisinone (Orfadin)FDA Link 01/2017
1	tau Proteins (tau Protein)IBA 07/2011
1	Botulinum Toxins (Botulinum Toxin)IBA 10/2010

Therapy/Procedure

1	Therapeutics 01/2024
1	Subcutaneous Infusions 12/2023
1	Telerehabilitation 11/2021
1	Deprescriptions 11/2017
1	Liver Transplantation 01/2017